Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Duggan-Keen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Human Heredity|January 1, 1985
DR antigens and Bf allotypes in north-east EnglandS S Papiha, M F Duggan-Keen, R S Rodger
Immunology|June 1, 1990
Immunoglobulin G subclasses secreted by human B cells in vitro in response to interleukin-2 and polyclonal activatorsJ E Calvert, R Johnstone, M F Duggan-Keen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 4, 1998
Papillomavirus vaccinesM F Duggan-Keen, M D Brown, S N Stacey, et al.
Autoimmunity|January 1, 1988
The CD5+ B cell: a B cell lineage with a central role in autoimmune disease?J E Calvert, M F Duggan-Keen, S W Smith, et al.
Disease Markers|March 1, 1990
B cell differentiation and lymphocyte surface phenotype in late onset hypogammaglobulinaemiaM F Duggan-Keen, A G Bird, P Bird, et al.
Immunogenetics|November 4, 2000
A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cellsA Serrano, C S Brady, P Jimenez, et al.
Nature Medicine|May 1, 1995
The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerJ R Ellis, P J Keating, J Baird, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|August 1, 1996
Immunogenetic factors in HPV-associated cervical cancer: influence on disease progressionM F Duggan-Keen, P J Keating, F R Stevens, et al.
Tissue Antigens|July 8, 2000
Multiple mechanisms underlie HLA dysregulation in cervical cancerC S Brady, J S Bartholomew, D J Burt, et al.
Cancer Research|May 1, 1998
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal studyT D de Gruijl, H J Bontkes, J M Walboomers, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Human Heredity|January 1, 1985
DR antigens and Bf allotypes in north-east EnglandS S Papiha, M F Duggan-Keen, R S Rodger
Immunology|June 1, 1990
Immunoglobulin G subclasses secreted by human B cells in vitro in response to interleukin-2 and polyclonal activatorsJ E Calvert, R Johnstone, M F Duggan-Keen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 4, 1998
Papillomavirus vaccinesM F Duggan-Keen, M D Brown, S N Stacey, et al.
Autoimmunity|January 1, 1988
The CD5+ B cell: a B cell lineage with a central role in autoimmune disease?J E Calvert, M F Duggan-Keen, S W Smith, et al.
Disease Markers|March 1, 1990
B cell differentiation and lymphocyte surface phenotype in late onset hypogammaglobulinaemiaM F Duggan-Keen, A G Bird, P Bird, et al.
Immunogenetics|November 4, 2000
A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cellsA Serrano, C S Brady, P Jimenez, et al.
Nature Medicine|May 1, 1995
The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerJ R Ellis, P J Keating, J Baird, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|August 1, 1996
Immunogenetic factors in HPV-associated cervical cancer: influence on disease progressionM F Duggan-Keen, P J Keating, F R Stevens, et al.
Tissue Antigens|July 8, 2000
Multiple mechanisms underlie HLA dysregulation in cervical cancerC S Brady, J S Bartholomew, D J Burt, et al.
Cancer Research|May 1, 1998
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal studyT D de Gruijl, H J Bontkes, J M Walboomers, et al.
Pageof 2